ANDA 78359, held by Sun Pharm Inds. Desloratadine.
As of Nov 16, 2026, ANDA 78359 (Desloratadine), held by Sun Pharm Inds, was first approved by FDA on Nov 16, 2010, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 16, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desloratadine5MG · tablet;oral | Desloratadine | Discontinued |
| Oct 22, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Oct 22, 2019 | Supplement 3Labeling · Standard review | Approved | None posted |
| Oct 7, 2013 | Supplement 1Labeling · Standard review | Approved | None posted |
| Nov 16, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters